Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

Ret Proto-Oncogene Antikörper (pTyr1015)

RET Reaktivität: Human, Maus, Ratte, Affe WB, ELISA Wirt: Kaninchen Polyclonal unconjugated

Produktnummer ABIN3182216

Datenblatt (PDF)

Target Alle Ret Proto-Oncogene (RET) Antikörper anzeigen

Ret Proto-Oncogene (RET)
Bindungsspezifität
27

21

15

15

15

11

9

9

8

8

8

7

6

6

4

4

3

3

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
pTyr1015
Reaktivität
161

99

80

4

3

2

2

2

2

1

1

1

1

1

1
Human, Maus, Ratte, Affe
Wirt
184

22

2

1

1

1
Kaninchen
Passende Sekundärantikörper
Klonalität
180

31
Polyklonal
Konjugat
88

14

10

9

9

9

9

9

9

9

6

5

5

5

5

5

4

1
Dieser Ret Proto-Oncogene Antikörper ist unkonjugiert
Applikation
169

81

66

65

42

28

17

15

15

9

4

3

2

1

1

1

1

1

1
Western Blotting (WB), ELISA

Spezifität

Phospho-Ret (Y1015) Polyclonal Antibody detects endogenous levels of Ret protein only when phosphorylated at Y1015.

Produktmerkmale

Rabbit Polyclonal to Phospho-Ret (Y1015).

Aufreinigung

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Immunogen

Synthesized peptide derived from human Ret around the phosphorylation site of Y1015.

Isotyp

IgG

Top Product

Discover our top product RET Primärantikörper
anti-Ret Proto-Oncogene (RET) (AA 702-848) antibody
RET Reaktivität: Human IHC, StM Wirt: Maus Monoclonal RET-2795 unconjugated

anti-Ret Proto-Oncogene (RET) (AA 1-1072) antibody
RET Reaktivität: Human WB, PLA Wirt: Kaninchen Polyclonal unconjugated

anti-Ret Proto-Oncogene (RET) (AA 702-848) antibody
RET Reaktivität: Human ELISA, Coat Wirt: Maus Monoclonal RET-2663 unconjugated

anti-Ret Proto-Oncogene (RET) antibody
RET Reaktivität: Human WB Wirt: Kaninchen Monoclonal unconjugated

anti-Ret Proto-Oncogene (RET) (AA 152-182), (N-Term) antibody
RET Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB00705 unconjugated

anti-Ret Proto-Oncogene (RET) (AA 1012-1042), (C-Term) antibody
RET Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB01561 unconjugated

anti-Ret Proto-Oncogene (RET) (AA 361-458) antibody
RET Reaktivität: Human WB, ELISA, PLA Wirt: Maus Monoclonal 1A5 unconjugated

anti-Ret Proto-Oncogene (RET) (C-Term) antibody
RET Reaktivität: Human, Maus, Ratte WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Ret Proto-Oncogene (RET) (pTyr1062) antibody
RET Reaktivität: Human, Maus, Ratte WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Ret Proto-Oncogene (RET) (AA 29-300) antibody
RET Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated

Applikationshinweise

WB 1:500-1:2000, ELISA 1:5000,

Beschränkungen

Nur für Forschungszwecke einsetzbar
Format

Liquid

Konzentration

1 mg/mL

Buffer

Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

Konservierungsmittel

Sodium azide

Vorsichtsmaßnahmen

This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung

Avoid repeated freeze/thaw cycles.

Lagerung

-20 °C

Informationen zur Lagerung

Store at -20°C.
Target

Ret Proto-Oncogene (RET)

Andere Bezeichnung

Ret (RET Produkte)

Synonyme

c-ret antikoerper, cret antikoerper, etID315074.13 antikoerper, ret1 antikoerper, wu:fd13h01 antikoerper, X-ret antikoerper, ret-A antikoerper, xret antikoerper, RET antikoerper, MTC1 antikoerper, CDHF12 antikoerper, CDHR16 antikoerper, HSCR1 antikoerper, MEN2A antikoerper, MEN2B antikoerper, PTC antikoerper, RET-ELE1 antikoerper, RET51 antikoerper, RET9 antikoerper, c-Ret antikoerper, ret proto-oncogene receptor tyrosine kinase antikoerper, ret proto-oncogene S homeolog antikoerper, ret proto-oncogene antikoerper, ret antikoerper, ret.S antikoerper, RET antikoerper, Ret antikoerper

Molekulargewicht

124 kDa

Gen-ID

5979

UniProt

P07949

Pathways

RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation